Verrica Pharmaceuticals (VRCA) Assets (2017 - 2026)
Verrica Pharmaceuticals (VRCA) posted quarterly Assets of $38.8 million for Q1 2026, down 8.04% year-over-year from $42.2 million in Q1 2025, and down 17.71% quarter-over-quarter from $47.1 million in Q4 2025.
Verrica Pharmaceuticals (VRCA) Assets (2017 - 2026) Analysis & Trends
Verrica Pharmaceuticals' Assets history runs 10 years deep, the most recent figure standing at $38.8 million for Q1 2026.
- In Q1 2026, Assets fell 8.04% year-over-year to $38.8 million; the TTM figure through Mar 2026 stood at $38.8 million (down 8.04% YoY), while the FY2025 annual figure was $47.1 million, down 12.94% from the prior year.
- Assets for Q1 2026 stood at $38.8 million, down from $47.1 million in the prior quarter.
- The five-year high for Assets was $97.1 million in Q3 2023, with the low at $32.9 million in Q3 2024.
- The 5-year median for Assets is $52.0 million (2024), against an average of $56.0 million.
- The sharpest annual moves came in 2023 and 2024: Assets soared 97.67% in 2023, then tumbled 66.11% in 2024.
- Verrica Pharmaceuticals' Assets stood at $44.7 million in 2022, then soared by 82.46% to $81.6 million in 2023, then plunged by 33.66% to $54.1 million in 2024, then decreased by 12.94% to $47.1 million in 2025, then retreated by 17.71% to $38.8 million in 2026.
- Business Quant data shows VRCA's Assets at $38.8 million in Q1 2026, $47.1 million in Q4 2025, and $40.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.69 Bn | 130.84 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 86.29 Bn | 78.29 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.79 Bn | 59.60 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 59.44 Bn | 54.31 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 42.07 Bn | 36.97 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 30.92 Bn | 27.61 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.10 Bn | 9.71 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.33 Bn | 26.17 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.00 Bn | 26.17 Bn | - | 19.82 Bn |
| 10 | Verrica Pharmaceuticals | 106.31 Mn | 95.11 Mn | - | 36.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 36.02 Mn |
| Mar 31, 2026 | 38.79 Mn |
| Dec 31, 2025 | 47.13 Mn |
| Sep 30, 2025 | 40.90 Mn |
| Jun 30, 2025 | 39.11 Mn |
| Mar 31, 2025 | 42.18 Mn |
| Dec 31, 2024 | 54.13 Mn |
| Sep 30, 2024 | 32.93 Mn |
| Jun 30, 2024 | 52.01 Mn |
| Mar 31, 2024 | 66.31 Mn |
| Dec 31, 2023 | 81.60 Mn |
| Sep 30, 2023 | 97.15 Mn |
| Jun 30, 2023 | 62.20 Mn |
| Mar 31, 2023 | 68.64 Mn |
| Dec 31, 2022 | 44.72 Mn |
| Sep 30, 2022 | 49.15 Mn |
| Jun 30, 2022 | 63.44 Mn |
| Mar 31, 2022 | 71.62 Mn |
| Dec 31, 2021 | 80.13 Mn |
| Sep 30, 2021 | 88.76 Mn |